Scott Durbin joins Aastrom
This article was originally published in Scrip
Aastrom Biosciences, a US company developing autologous cellular therapies for the treatment of severe cardiovascular diseases, has appointed Scott Durbin chief financial officer. He has more than 15 years' healthcare-related banking, financial and corporate development experience, having previously served as chief operating officer and chief financial officer of Prescient Medical. Before that, he was a finance and corporate development consultant at Scios and Alteon.